Ahead of Market: 10 things that will decide stock market action on Monday

Ahead of Market: 10 things that will decide stock market action on Monday

The Indian market extended losses for a second consecutive week on Friday, dragged down by concerns over a delayed U.S. trade deal and disappointing quarterly results from Tata Consultancy Services. The Nifty 50 declined 1.22% to close at 25,149.85, while the BSE Sensex slipped 1.12% to 82,500.47 for the week. On the day, the Nifty … Read more

Accumulate quality stocks in strong sectors despite market noise: Rajesh Palviya

Accumulate quality stocks in strong sectors despite market noise: Rajesh Palviya

“Looking at the put-based concentration, Nifty is currently trading below the major put base at 25,300. On the call side as well, major writers have shifted their positions to the 25,300 and 25,200 strikes. This clearly indicates that we may witness further pressure if Nifty continues to trade below the 25,300 level next week. That … Read more

Comeback kings! Reliance Power, Reliance Infra among 40 turnaround stories of FY25. Watchlist material?

Comeback kings! Reliance Power, Reliance Infra among 40 turnaround stories of FY25. Watchlist material?

In a stunning reversal of fortune, at least 40 companies pulled off a comeback story, shifting from losses in FY24 to profits in FY25. Stocks of nine of these companies have rewarded investors with multibagger returns exceeding 100%. Leading this remarkable turnaround brigade is Anil Ambani-led Reliance Power, which catapulted from a staggering loss of … Read more

Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth

Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth

Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year. Revenue rose 7% YoY to Rs 3,434 crore in Q2FY25. EBITDA grew 30.2% YoY to Rs 602 crore, … Read more

Stocks to buy today: 9 short-term trading ideas by experts for 18 December, 2023

Stocks to buy today: 9 short-term trading ideas by experts for 18 December, 2023

Indian headline indices hit fresh lifetime highs on Friday ending with weekly gains of 2.7% on a dovish pivot by the US Fed. The biggest gainers were IT and bank stocks. Nifty hit a new lifetime high of 21,492.30 before ending the session at 21,456.65, up 273.95 points or 1.29%. The 30-stock S&P BSE Sensex … Read more

Radhakishan Damani, Hemendra Kothari among India’s top stock market investors

Radhakishan Damani, Hemendra Kothari among India’s top stock market investors

TAQA Looks to Bet Big on Adani’s Power Biz Abu Dhabi National Energy Co. PJSC (TAQA) is looking to double down on India and is evaluating a large exposure in the expansive power businesses of Gautam Adani that span thermal generation to transmission, clean energy and green hydrogen, said people aware of the matter. Big … Read more

Stocks to buy today: Tata Motors, SBI among top 6 trading ideas for 10 July 2023

Stocks to buy today: Tata Motors, SBI among top 6 trading ideas for 10 July 2023

Indian market is likely to consolidate on Monday tracking mixed global cues. The S&P BSE Sensex fell more than 500 points while the Nifty50 closed below 19400 levels on Friday. India VIX was down by 2.60% from 11.84 to 11.53 levels on Friday. Volatility sunk lower and is hovering near its lower band which may … Read more

Big Movers on D-St: What should investors do with Raymond, Glenmark Pharma and KPIT Technologies?

Big Movers on D-St: What should investors do with Raymond, Glenmark Pharma and KPIT Technologies?

Indian market closed in the green for the sixth day in a row on Thursday following positive global cues. The S&P BSE Sensex rose more than 300 points while Nifty50 closed above 17900 levels. Sectorally, buying was seen in realty, telecom, IT, auto, and metals while selling was visible in power, and infra stocks. Stocks … Read more

Can PLI, China Plus One keep India’s pharma sector in pink of health?

Can PLI, China Plus One keep India’s pharma sector in pink of health?

The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more